Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Shingrix (herpes zoster subunit vaccine) for the Prevention of Shingles

Developer

GlaxoSmithKline (GSK)

Therapy Class

Recombinant subunit vaccine

Current Indication

Shingles

Market Sector

Anti-infectives

Development Status

Approved in the US and Canada
Expand

Go Top